Once again: this is a phase 1 trial. They are testing to make sure there are no serious side effects of the treatment, hence they have different doses for different patients, and most aren't being treated at the optimal dose level.
Ann: Third complete response in PTX-200 AML Trial, page-215
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
-0.001(2.44%) |
Mkt cap ! $32.21M | |||
| Open | High | Low | Value | Volume |
| 4.0¢ | 4.1¢ | 4.0¢ | $33.59K | 837.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 106436 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 119449 | 3 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| PTX (ASX) Chart |